Xun Dong
Director/Board Member at SINOMAB BIOSCIENCE LIMITED
Profile
Xun Dong is currently the Director at Yunnan Institute of Materia Medica and a Non-Executive Director at Sinomab Bioscience Ltd.
He previously worked as the Vice President-Sales at Yunnan Baiyao Group Co., Ltd.
Mr. Dong received his graduate degree from the University of Warwick in 2010 and his undergraduate degree from Southampton Business School in 2009.
Xun Dong active positions
Companies | Position | Start |
---|---|---|
SINOMAB BIOSCIENCE LIMITED | Director/Board Member | 2019-12-22 |
Yunnan Institute of Materia Medica
Yunnan Institute of Materia Medica Pharmaceuticals: MajorHealth Technology Part of Yunnan Baiyao Group Co., Ltd., Yunnan Institute of Materia Medica is a Chinese pharmaceutical company that manufactures and distributes drugs. The private company is based in Kunming, China. Yunnan Institute of Materia Medica was acquired by Yunnan Baiyao Group Co., Ltd. from Yunnan Baiyao Holdings Co., Ltd. on November 26, 2012 for $16.13 million. | Director/Board Member | - |
Former positions of Xun Dong
Companies | Position | End |
---|---|---|
YUNNAN BAIYAO GROUP CO.,LTD | Sales & Marketing | - |
Training of Xun Dong
University of Warwick | Graduate Degree |
Southampton Business School | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 2 |
---|---|
YUNNAN BAIYAO GROUP CO.,LTD | Health Technology |
SINOMAB BIOSCIENCE LIMITED | Health Technology |
Private companies | 1 |
---|---|
Yunnan Institute of Materia Medica
Yunnan Institute of Materia Medica Pharmaceuticals: MajorHealth Technology Part of Yunnan Baiyao Group Co., Ltd., Yunnan Institute of Materia Medica is a Chinese pharmaceutical company that manufactures and distributes drugs. The private company is based in Kunming, China. Yunnan Institute of Materia Medica was acquired by Yunnan Baiyao Group Co., Ltd. from Yunnan Baiyao Holdings Co., Ltd. on November 26, 2012 for $16.13 million. | Health Technology |
- Stock Market
- Insiders
- Xun Dong